A detailed history of Quest Partners LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 15,034 shares of HRMY stock, worth $520,176. This represents 0.06% of its overall portfolio holdings.

Number of Shares
15,034
Previous 4,395 242.07%
Holding current value
$520,176
Previous $148 Million 207.33%
% of portfolio
0.06%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$28.81 - $33.01 $306,509 - $351,193
10,639 Added 242.07%
15,034 $454 Million
Q1 2024

May 09, 2024

BUY
$29.93 - $35.06 $120,558 - $141,221
4,028 Added 1097.55%
4,395 $148 Million
Q4 2023

Feb 09, 2024

BUY
$19.2 - $33.78 $7,046 - $12,397
367 New
367 $11.9 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.05B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.